Literature DB >> 16482558

Unique BK virus non-coding control region (NCCR) variants in hematopoietic stem cell transplant recipients with and without hemorrhagic cystitis.

Michael J Carr1, Grace P McCormack, Ken J Mutton, Brendan Crowley.   

Abstract

Hematopoietic stem cell transplant recipients frequently develop BK virus (BKV)-associated hemorrhagic cystitis, which coincides with BK viruria. However, the precise role of BKV in the etiology of hemorrhagic cystitis in hematopoietic stem cell transplant recipients remains unclear, since approximately 50% of all such adult transplant recipients excrete BKV, yet do not develop this clinical condition. In the present study, BKV were analyzed to determine if mutations in the non-coding control region (NCCR), and specific BKV sub-types defined by sequence analysis of major capsid protein VP1, were associated with development of hemorrhagic cystitis in hematopoietic stem cell transplant recipients. The regions encoding VP1 and NCCRs of BKV in urine samples collected from 15 hematopoietic stem cell transplant recipients with hemorrhagic cystitis and 20 without this illness were amplified and sequenced. Sequence variations in the NCCRs of BKV were identified in urine samples from those with and without hemorrhagic cystitis. Furthermore, five unique sequence variations within transcription factor binding sites in the canonical NCCR, O-P-Q-R-S, were identified, representing new BKV variants from a population of cloned quasi-species obtained from patients with and without hemorrhagic cystitis. Thirty-five BKV VP1 sequences were analyzed by phylogenetic analysis but no specific BKV sub-type was associated with hemorrhagic cystitis. Five previously unrecognized naturally occurring variants of the BKV are described which involve amplifications, deletions, and rearrangements of the archetypal BKV NCCRs in individuals with and without hemorrhagic cystitis. Architectural rearrangements in the NCCRs of BKV did not appear to be a prerequisite for development of hemorrhagic cystitis in hematopoietic stem cell transplant recipients. Copyright 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16482558     DOI: 10.1002/jmv.20566

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  15 in total

1.  VP-1 quasispecies in human infection with polyomavirus BK.

Authors:  Chunqing Luo; Hans H Hirsch; Jeffrey Kant; Parmjeet Randhawa
Journal:  J Med Virol       Date:  2011-11-03       Impact factor: 2.327

Review 2.  BK Polyomavirus: Clinical Aspects, Immune Regulation, and Emerging Therapies.

Authors:  George R Ambalathingal; Ross S Francis; Mark J Smyth; Corey Smith; Rajiv Khanna
Journal:  Clin Microbiol Rev       Date:  2017-04       Impact factor: 26.132

Review 3.  BK polyomavirus diversity-Why viral variation matters.

Authors:  Jason T Blackard; Stella M Davies; Benjamin L Laskin
Journal:  Rev Med Virol       Date:  2020-03-03       Impact factor: 6.989

4.  Limited Variation in BK Virus T-Cell Epitopes Revealed by Next-Generation Sequencing.

Authors:  Malaya K Sahoo; Susanna K Tan; Sharon F Chen; Beatrix Kapusinszky; Katherine R Concepcion; Lynn Kjelson; Kalyan Mallempati; Heidi M Farina; Marcelo Fernández-Viña; Dolly Tyan; Paul C Grimm; Matthew W Anderson; Waldo Concepcion; Benjamin A Pinsky
Journal:  J Clin Microbiol       Date:  2015-07-22       Impact factor: 5.948

5.  An Asian origin for subtype IV BK virus based on phylogenetic analysis.

Authors:  Yuriko Nishimoto; Huai-Ying Zheng; Shan Zhong; Hiroshi Ikegaya; Qin Chen; Chie Sugimoto; Tadaichi Kitamura; Yoshiaki Yogo
Journal:  J Mol Evol       Date:  2007-06-25       Impact factor: 2.395

6.  High frequency and diversity of rearrangements in polyomavirus bk noncoding regulatory regions cloned from urine and plasma of Israeli renal transplant patients and evidence for a new genetic subtype.

Authors:  Tsachi Tsadok Perets; Ilana Silberstein; Jana Rubinov; Ronit Sarid; Ella Mendelson; Lester M Shulman
Journal:  J Clin Microbiol       Date:  2009-03-04       Impact factor: 5.948

7.  BK polyomavirus reactivation after reduced-intensity double umbilical cord blood cell transplantation.

Authors:  Gowri Satyanarayana; Sarah P Hammond; Thomas A Broge; Matthew R Mackenzie; Raphael Viscidi; Ioannis Politikos; Igor J Koralnik; Corey S Cutler; Karen Ballen; Vassiliki Boussiotis; Francisco M Marty; Chen Sabrina Tan
Journal:  Transpl Immunol       Date:  2014-12-20       Impact factor: 1.708

8.  Reactivation of BK polyomavirus in patients with multiple sclerosis receiving natalizumab therapy.

Authors:  Roisin M Lonergan; Michael J Carr; Cillian F De Gascun; Lisa F Costelloe; Allison Waters; Suzie Coughlan; Marguerite Duggan; Katie Doyle; Sinead Jordan; Michael W Hutchinson; William W Hall; Niall J Tubridy
Journal:  J Neurovirol       Date:  2009-09       Impact factor: 2.643

9.  Progression from Sustained BK Viruria to Sustained BK Viremia with Immunosuppression Reduction Is Not Associated with Changes in the Noncoding Control Region of the BK Virus Genome.

Authors:  Imran A Memon; Bijal A Parikh; Monique Gaudreault-Keener; Rebecca Skelton; Gregory A Storch; Daniel C Brennan
Journal:  J Transplant       Date:  2012-06-04

Review 10.  Human polyomavirus reactivation: disease pathogenesis and treatment approaches.

Authors:  Cillian F De Gascun; Michael J Carr
Journal:  Clin Dev Immunol       Date:  2013-05-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.